- Home
- PLXS vs ACLX Comparison
PLXS vs ACLX Comparison
Compare PLXS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLXS | ACLX |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.2B |
| IPO Year | 1986 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PLXS | ACLX |
|---|---|---|
| Price | $154.02 | $65.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $160.00 | $115.71 |
| AVG Volume (30 Days) | 197.4K | ★ 1.3M |
| Earning Date | 01-21-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.11 | N/A |
| EPS | ★ 6.26 | N/A |
| Revenue | ★ $4,032,966,000.00 | $35,898,000.00 |
| Revenue This Year | $10.99 | N/A |
| Revenue Next Year | $7.02 | $293.08 |
| P/E Ratio | $24.64 | ★ N/A |
| Revenue Growth | ★ 1.82 | N/A |
| 52 Week Low | $103.43 | $47.86 |
| 52 Week High | $172.89 | $94.07 |
Technical Indicators
Market Signals| Indicator | PLXS | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 35.52 |
| Support Level | $151.94 | $63.48 |
| Resistance Level | $156.41 | $66.79 |
| Average True Range (ATR) | 5.19 | 3.40 |
| MACD | -0.52 | 0.14 |
| Stochastic Oscillator | 34.39 | 13.55 |
Price Performance
Historical ComparisonAbout PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.